Abdominal fat mass is associated with adaptive immune activation: The CODAM study

Obesity

Volumn 19, Issue 8, 2011, Pages 1690-1698

  Thewissen, Marielle M ^a,b   Damoiseaux, Jan G ^a   Duijvestijn, Adriaan M ^a,b   Van Greevenbroek, Marleen M ^a,b   Van Der Kallen, Carla J ^a,b   Feskens, Edith J ^a,d   Blaak, Ellen E ^a,b,c   Schalkwijk, Casper G ^a,b   Stehouwer, Coen D ^a,b   Tervaert, Jan W Cohen ^a,b   Ferreira, Isabel ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; NEOPTERIN; SERUM AMYLOID A;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADAPTIVE IMMUNITY; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HUMAN; INNATE IMMUNITY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADAPTIVE IMMUNITY; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNITY, INNATE; INSULIN RESISTANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPTERIN; OBESITY, ABDOMINAL; SERUM AMYLOID A PROTEIN; WAIST CIRCUMFERENCE;

EID: 79960837611     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.337     Document Type: Article

References (44)

1. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
2. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009;53:577-584.
3. Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 2007;65:S152-S156.
4. Fernández-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2008;19:10-16.
5. Hak AE, Stehouwer CD, Bots ML et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999;19: 1986-1991. (Pubitemid 29379933)
6. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29: 2959-2971.
7. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796-1808. (Pubitemid 38063703)
8. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003;278:45777-45784. (Pubitemid 37432722)
9. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610-614. (Pubitemid 27446179)
10. Kintscher U, Hartge M, Hess K et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1304-1310.
11. Rocha VZ, Folco EJ, Sukhova G et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008;103:467-476.
12. Nishimura S, Manabe I, Nagasaki M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-920.
13. Winer S, Chan Y, Paltser G et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009;15:921-929.
14. Feuerer M, Herrero L, Cipolletta D et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009;15:930-939.
15. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997;40: 1286-1292. (Pubitemid 27469668)
16. Rubin LA, Kurman CC, Fritz ME et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985;135: 3172-3177. (Pubitemid 16250575)
17. Brusko TM, Wasserfall CH, Hulme MA et al. Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation. PLoS ONE 2009;4:e7980.
18. Popa ER, Stegeman CA, Bos NA, Kallenberg CG, Tervaert JW. Differential B-and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999;103:885-894. (Pubitemid 29297593)
19. Bien E, Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers 2008;13:1-26.
20. Makis AC, Galanakis E, Hatzimichael EC et al. Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis. J Infect 2005;51:206-210. (Pubitemid 41554828)
21. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992;29: 307-341. (Pubitemid 23011151)
22. Klein S, Allison DB, Heymsfield SB et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 2007;30: 1647-1652.
23. Du H, van der A DL, van Bakel MM et al. Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. Am J Clin Nutr 2008;87:655-661. (Pubitemid 351364547)
24. Jacobs M, van Greevenbroek MM, van der Kallen CJ et al. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest 2009;39: 437-444.
25. WHO. Definition, diagnosis, and classification of diabetes mellitus. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2: Geneva, Switzerland, 1999.
26. Chobanian AV, Bakris GL, Black HR et al.; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252. (Pubitemid 37553153)
27. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
28. Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 2002;7:422-445.
29. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004;36:717-731. (Pubitemid 40251423)
30. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-891.
31. Hayes AF. Beyond Baron and Kenny: statistical mediation analysis in the new millenium. Commun Monogr 2009;76:408-420.
32. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 2006;6:358-370.
33. Viardot A, Lord RV, Samaras K. The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 2010;95:2845-2850.
34. Ledochowski M, Murr C, Widner B, Fuchs D. Association between insulin resistance, body mass and neopterin concentrations. Clin Chim Acta 1999;282:115-123. (Pubitemid 29179476)
35. Bozdemir AE, Barutcuoglu B, Dereli D et al. C-reactive protein and neopterin levels in healthy non-obese adults. Clin Chem Lab Med 2006;44:317-321. (Pubitemid 43357692)
36. Ursavas A, Karadag M, Oral AY et al. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med 2008;102:1193-1197.
37. Mescher MF, Curtsinger JM, Agarwal P et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 2006;211:81-92. (Pubitemid 43882963)
38. Maroof A, Beattie L, Kirby A, Coles M, Kaye PM. Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen. J Immunol 2009;183:7095-7103.
39. Viardot A, Grey ST, Mackay F, Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 2007;148:346-353. (Pubitemid 46021467)
40. Guzik TJ, Hoch NE, Brown KA et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-2460. (Pubitemid 47529329)
41. Madhur MS, Lob HE, McCann LA et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010;55:500-507.
42. Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol 2010;134:33-46.
43. Stemme S, Faber B, Holm J et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995;92:3893-3897.
44. Huber C, Batchelor JR, Fuchs D et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160:310-316. (Pubitemid 14089799)